KBKate Brain

Kate Brain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kate Brain has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Liz France

    From the Institute of Medical Genetics, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, United Kingdom

    2 shared publications
  • A. Clements

    Cancer Research UK, Primary Care Education Research Group, Division of Public Health, Primary Health Care, University of Oxford, Old Road, Headington, Oxford OX3 7LF, UK

    1 shared publication
  • Angus Clarke

    The Institute of Medical Genetics, University of Wales Healthcare NHS Trust Cardiff

    1 shared publication
  • B. J. Henderson

    Institute of Medical and Social Care Research, Ardudwy, Normal Site, University of Wales, Bangor, Gwynedd LL57 2PX, UK

    1 shared publication
  • Buddug Williams

    From the Institute of Medical Genetics, School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, United Kingdom

    1 shared publication
  • C. Bankhead

    Cancer Research UK, Primary Care Education Research Group, Division of Public Health, Primary Health Care, University of Oxford, Old Road, Headington, Oxford OX3 7LF, UK

    1 shared publication

Latest Publications

  • Predictors of breast cancer‐related distress following mammography screening in younger women on a family history breast screening programme

    by K. Brain, B. J. Henderson, S. Tyndel, C. Bankhead, E. Watson, A. Clements, J. Austoker, for the PIMMS Study Management Group

    Objective: This longitudinal study investigated pre‐screening factors that predicted breast cancer‐specific distress among 1286 women who were undergoing annual mammography screening as part of a UK programme for younger women (i.e., under 50) with a family history of breast cancer.Methods: Women completed questionnaires one month prior to screening, and one and six months after receiving screening results. Factors measured were breast cancer worry, perceived risk, cognitive appraisals, coping, dispositional optimism, and background variables relating to screening history and family history.Results: Pre‐screening cancer worry was the most important predictor of subsequent worry, explaining 56/61% and 54/57% of the variance at one and six months follow‐up, respectively. Other salient pre‐screening predictors included high perceived risk of breast cancer, appraisals of high relevance and threat associated with the family history, and low perceived ability to cope emotionally. Women who had previously been part of the screening programme and those with a relative who had recently died from breast cancer were also vulnerable to longer‐term distress. A false positive screening result, pessimistic personality, and coping efforts relating to religion and substance use predicted outcomes of screening at one month follow‐up, but were not predictive in the longer‐term.Conclusion: Early intervention to ameliorate high levels of cancer‐related distress and negative appraisals would benefit some women as they progress through the familial breast screening programme. Copyright © 2008 John Wiley & Sons, Ltd.


  • Psychological Distress in Men With Breast Cancer

    by Kate Brain, Buddug Williams, Rachel Iredale, Liz France, Jonathon Gray

    Purpose: This article reports the first United Kingdom study to examine the prevalence of psychological distress in men with breast cancer and the factors associated with increased distress. Patients and Methods: One hundred and sixty-one men with breast cancer completed a cross-sectional questionnaire that included measures of anxiety and depressive symptoms, cancer-specific distress, body image, coping, information and support needs, and clinical and demographic variables. Results: Clinical levels of anxiety and depressive symptoms were reported by 6% and 1% of men, respectively, while 23% reported high levels of cancer-specific distress. Anxiety was most strongly associated with avoidance coping and fear and uncertainty about the future (42% of the variance in anxiety scores, P < .001). Depressive symptoms were associated with altered body image (35% of the variance, P < .001). Body image, avoidance coping, referral to the study by a clinician, fear and uncertainty, and wanting to receive more gender-specific information together explained 51% of the variance in cancer-related distress (P < .001). Clinical and demographic factors did not account for a significant proportion of the variance in any of the distress measures. Conclusion: Although the prevalence of clinical anxiety and depressive symptoms were low in this sample, almost a quarter of men experienced traumatic stress symptoms specific to breast cancer. Potential risk factors for distress include the use of avoidant coping strategies, negative body image, feelings of fear and uncertainty in relation to breast cancer, and unmet information needs. Suggestions are made for improving the information and support available to men with breast cancer.


  • An exploratory comparison of genetic counselling protocols for HNPCC predictive testing

    by K Brain, S Sivell, K Bennert, L Howell, L France, S Jordan, Mt Rogers, J Gray, J Sampson

    Most UK genetics centres offering predictive testing for hereditary non-polyposis colorectal cancer (HNPCC) use an extended counselling protocol originally developed for Huntington's disease. Shortened counselling may be more appropriate in the context of treatable genetic conditions such as HNPCC. Twenty-six high-risk individuals were randomized to extended genetic counselling (two sessions of education and reflection held 1 month apart) or shortened genetic counselling (a single educational session) prior to HNPCC testing. Prospective questionnaires, interviews and transcripts of counselling sessions were analysed. Participants were unsure what to expect prior to genetic counselling and had already decided to undergo genetic testing. There was no evidence of psychological harm caused by shortened genetic counselling, with a high level of satisfaction with the counselling received in both groups. Reflective counselling occurred in both groups but was framed in terms of practical action and information. Participants expressed differing preferences for the level of information received. This exploratory study indicates that shortened genetic counselling may be an appropriate means of supporting decisions already made by individuals about HNPCC testing. However, participants would benefit from preparatory information to help them reflect on issues not previously considered, which can then be explored more fully as part of a tailored counselling approach


  • Open Access

    Genetic Testing Considerations in Breast Cancer Patients

    by Liz France, Jonathon Gray, Glyn Elwyn, Mark Tischkowitz, Kate Brain, Julian Sampson, Cathy Anglim, Angus Clarke, Evelyn Parsons, Helen Sweetland, et al.

    Genetic testing is now feasible for a growing number of cancers. Although the implications for unaffected relatives have been widely described, the impact of the tests on affected individuals are often not recognized. We present and discuss four cases that highlight some of the issues—for example, feelings of guilt and anxiety, intrafamilial conflict, and support needs—that may arise in testing affected individuals. We offer some suggestions to aid in the approach to such testing.